Data managers and CRAs warn of rising data quality risks due to trial inefficiencies
A new industry report uncovers the scope of a long-ignored problem in clinical trial operations: deep inefficiencies caused by manual workflows and fragmented systems will likely put clinical data quality at future risk.
Veeva surveyed more than 85 data managers and CRAs across sponsors and clinical research organizations (CROs) who use various technologies to execute clinical trials. The report examines productivity in Phase III trials, identifies root causes, and offers insights for advancement.
The Clinical Data Research Report shows data managers are currently losing an estimated 12 hours per week per study to time-consuming tasks like manual data reconciliation and data review & cleaning. Similarly, CRAs report excessive time spent updating multiple systems, writing reports, and following up with sites.
Read Veeva’s new industry report by clicking on the button below.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
